This article was written by Follow Buyside analyst covering global stocks on Seeking Alpha since 2018. I’ve been investing personally and professionally across major...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
Originally posted on October 7, 2023 In this weekly market report, we look at the various asset classes, sectors, equity categories, and exchange-traded funds...
What’s the best-performing sector in 2023? You might say something tech-related. While that is true among large-cap US equities, small and mid-sized companies within...
At a Glance In light of Lyra Therapeutics’ (NASDAQ:LYRA) recent financial and clinical data, investors face a complex investment landscape. On the clinical side,...
After Lucid Group (NASDAQ:LCID) disappointed multiple times with its delivery achievements in FY 2023 and dropped its EV prices by a considerable percentage, the...